Skip to main content
Log in

Risedronic acid vs ibandronic acid: a cost-effective analysis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Grima D, Borisov NN.Cost-effectiveness of risedronate vs. ibandronate: impact of discounts. Journal of Bone and Mineral Research 22 (Suppl. 1): 442, 2007

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Risedronic acid vs ibandronic acid: a cost-effective analysis. Pharmacoecon. Outcomes News 539, 1 (2007). https://doi.org/10.2165/00151234-200705390-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705390-00001

Keywords

Navigation